Cell Therapy Manufacturing Is Hitting a Scalabilit..

Criou um novo artigo

15 horas atrás - Traduzir

Cell Therapy Manufacturing Is Hitting a Scalability Wall And Most Companies Are Unprepared | #Market&Minds

Cell Therapy Manufacturing Is Hitting a Scalability Wall And Most Companies Are Unprepared

The promise of personalized medicine is colliding with industrial reality. As CAR-T therapies and regenerative treatments move from clinical trials to commercial scale, manufacturers are discovering that manual processing methods cannot support the volume, consistency, or economics require

Cell Therapy Manufacturing Is Hitting a Scalability Wall And Most Companies Are Unprepared